Live Breaking News & Updates on E Fund Management Co

Stay updated with breaking news from E fund management co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) CEO Sells $9,203,857.52 in Stock

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) CEO Leonard S. Schleifer sold 9,064 shares of Regeneron Pharmaceuticals stock in a transaction that occurred on Tuesday, June 11th. The stock was sold at an average price of $1,015.43, for a total transaction of $9,203,857.52. Following the transaction, the chief executive officer now owns 55,134 shares […] ....

Leonards Schleifer , Catalyst Capital Advisors , E Fund Management Co , Hedge Funds Weigh In On Regeneron Pharmaceuticals , Cantor Fitzgerald , Regeneron Pharmaceuticals Stock Down , News Ratings For Regeneron Pharmaceuticals Daily , Quarter For Regeneron Pharmaceuticals , Fund Management Co , Royal Bank , Fiera Capital Corp , Regeneron Pharmaceuticals , Capital Investment Advisors , Regeneron Pharmaceuticals Inc , Get Free Report , Pharmaceuticals Stock Down , Capital Corp , Capital Advisors , Fund Management , Regeneron Pharmaceuticals Daily ,

Forefront Analytics LLC Purchases New Position in Cogent Biosciences, Inc. (NASDAQ:COGT)

Forefront Analytics LLC purchased a new position in shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) during the fourth quarter, HoldingsChannel.com reports. The fund purchased 19,982 shares of the technology company’s stock, valued at approximately $117,000. A number of other large investors have also made changes to their positions in COGT. AJOVista LLC acquired […] ....

Robertw Baird , Cogent Biosciences Inc , Forefront Analytics , Dynamic Technology Lab Private Ltd , E Fund Management Co , Needham Company , Jpmorgan Chase Co , Investment Management , China Universal Asset Management Co , Cogent Biosciences , Free Report , Universal Asset Management , Technology Lab Private Ltd , Biosciences Trading Down , Get Free Report , Visit Holdingschannel , Cogent Biosciences Daily ,

Bain Capital Investors LLC Has $2.78 Billion Stock Holdings in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)

Bain Capital Investors LLC lifted its position in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Free Report) by 9.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 65,679,781 shares of the biotechnology company’s stock after purchasing an additional 5,480,052 shares during the quarter. […] ....

United States , N Anthony Coles , Cerevel Therapeutics Holdings Inc , Fund Management Co , E Fund Management Co , Cerevel Therapeutics Company Profile , Pacific Capital Wealth Advisors Inc , Financial Services Group Inc , Bain Capital Investors , Cerevel Therapeutics Holdings , Free Report , Capital Investors , Cerevel Therapeutics , Capital Wealth Advisors , Services Group , Fund Management , Dark Forest Capital Management , Therapeutics Holdings , Get Free Report , Directorn Anthony Coles , Visit Holdingschannel , Cerevel Therapeutics Daily ,

MiMedx Group (NASDAQ:MDXG) Upgraded at StockNews.com

MiMedx Group (NASDAQ:MDXG – Get Free Report) was upgraded by research analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a note issued to investors on Monday. Other equities research analysts have also issued research reports about the stock. Lake Street Capital initiated coverage on shares of MiMedx Group in a research […] ....

Dekabank Deutsche Girozentrale , Mimedx Group , Mimedx Group Stock Down , News Ratings For Mimedx Group Daily , Securities Exchange Commission , Mimedx Group Company Profile , Mimedx Group Inc , Institutional Trading Of Mimedx Group , Victory Capital Management Inc , Headlands Technologies , E Fund Management Co , Get Free Report , Street Capital , Medx Group Stock Down , Medx Group , Frank Iv Hulse , Exchange Commission , Bank Deutsche Girozentrale , Fund Management , Victory Capital Management , Mimedx Group Daily ,

Travere Therapeutics, Inc. (NASDAQ:TVTX) Stake Boosted by Crestline Management LP

Crestline Management LP raised its position in Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) by 32.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 81,423 shares of the company’s stock after purchasing an additional 20,002 shares during the quarter. Crestline […] ....

United States , E Fund Management Co , Mirae Asset Global Investments Co , Exchange Commission , Wells Fargo Company , Travere Therapeutics Inc , Fund Management Co , Canaccord Genuity Group , Crestline Management , Travere Therapeutics , Free Report , Retirement System , State Retirement System , Asset Global Investments , Fund Management , Get Free Report , Genuity Group , Wells Fargo , Iga Nephropathy , Travere Therapeutics Daily ,